All Stories

  1. New-onset of postoperative atrial fibrillation is likely to recur in the absence of other triggers
  2. Does Left Atrial Appendage Amputation During Routine Cardiac Surgery Reduce Future Atrial Fibrillation and Stroke?
  3. DESIGN FOR HEALTH: TOWARDS COLLABORATIVE CARE
  4. Low diagnostic yield of non-invasive testing in patients with suspected coronary artery disease: results from a large unselected hospital-based sample
  5. Quality of care for people with multimorbidity – a case series
  6. The Role of Glycated Proteins on Cardiovascular Diabetic Complications
  7. Performance of short ECG recordings twice daily to detect paroxysmal atrial fibrillation in stroke and transient ischemic attack patients
  8. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists
  9. Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells
  10. Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation
  11. H2O2 Treatment of HUVECs Facilitates PKC Mediated Thr495 Phosphorylation on eNOS when Pre-treated with High Glucose Levels
  12. Long-term treament with T3 hormone for patients with heart failure
  13. P189Vascular ageing is apparent during an oral glucose challenge in healthy humans
  14. Chronic liothyronine (T3) treatment in stable heart failure patients with low T3 syndrome: A randomised, double-blind, cross-over, placebo-controlled intervention study (The LIHFA study)
  15. Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
  16. Endothelial Nitric Oxide Synthase Phosphorylation at Threonine 495 and Mitochondrial Reactive Oxygen Species Formation in Response to a High H2O2 Concentration
  17. Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
  18. Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation
  19. The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive
  20. Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study
  21. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
  22. Ingestion of Broccoli Sprouts Does Not Improve Endothelial Function in Humans with Hypertension
  23. Atrial fibrillation in heart failure is associated with an increased risk of death only in patients with ischaemic heart disease
  24. ATRIAL FIBRILLATION IN HEART FAILURE IS ASSOCIATED WITH AN INCREASED RISK OF DEATH ONLY IN PATIENTS WITH ISCHEMIC HEART DISEASE
  25. Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study
  26. National Background is Associated with Disparities in Initiation and Persistence to Statin Treatment in Subjects with Diabetes in Denmark
  27. Initiation and Persistence to Statin Treatment in Patients with Diabetes Receiving Glucose-Lowering Medications 1997- 2006
  28. Gene Expression in Skeletal Muscle Biopsies from People with Type 2 Diabetes and Relatives: Differential Regulation of Insulin Signaling Pathways
  29. Effects of Acute and Chronic Attenuation of Postprandial Hyperglycemia on Postglucose-load Endothelial Function in Insulin Resistant Individuals: Is Stimulation of First Phase Insulin Secretion Beneficial for the Endothelial Function?
  30. Insulin Resistance: The Cardiovascular Aspect
  31. Effects of Oral Glucose Load on Endothelial Function and on Insulin and Glucose Fluctuations in Healthy Individuals
  32. Phosphorylative regulation of eNOS on thr495 and ser1177 during high glucose concentrations in HUVECs
  33. Quinapril Treatment Increases Insulin-Stimulated Endothelial Function and Adiponectin Gene Expression in Patients with Type 2 Diabetes
  34. T01-P-016 The insulin resistance syndrome and endothelial dysfunction — Does nateglinide make a difference?
  35. Metabolic and Vascular Effects of Tumor Necrosis Factor-α Blockade with Etanercept in Obese Patients with Type 2 Diabetes
  36. Prolonged Local Forearm Hyperinsulinemia Induces Sustained Enhancement of Nitric Oxide–Dependent Vasodilation in Healthy Subjects
  37. Tumor Necrosis Factor-  Inhibits Insulin's Stimulating Effect on Glucose Uptake and Endothelium-Dependent Vasodilation in Humans
  38. Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects
  39. Tumor necrosis factor-a infusion impairs endothelial function and induces endothelial and metabolic insulin resistance in humans
  40. Normal Insulin-Stimulated Endothelial Function and Impaired Insulin-Stimulated Muscle Glucose Uptake in Young Adults with Low Birth Weight
  41. Prognostic value of exercise testing in a cohort of patients followed for 15 years after acute myocardial infarction
  42. Subarachnoid Haemorrhage with Transient Myocardial Injury and Normal Coronary Arteries
  43. Multiple pulmonary chondrohamartomas in trachea, bronchi and lung parenchyma. Review of the literature